Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 294

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiology

Open access
Chou, David B., Frismantas, Viktoras, Milton, Yuka, David, Rhiannon, Pop-Damkov, Petar, Ferguson, Douglas, MacDonald, Alexander, Vargel Bölükbaşı, Özge, Joyce, Cailin E., Moreira Teixeira, Liliana S., Rech, Arianna, Jiang, Amanda, Calamari, Elizabeth, Jalili-Firoozinezhad, Sasan, Furlong, Brooke A., O’Sullivan, Lucy R., Ng, Carlos F., Choe, Youngjae, Marquez, Susan, Myers, Kasiani C., Weinberg, Olga K., Hasserjian, Robert P., Novak, Richard, Levy, Oren, Prantil-Baun, Rachelle, Novina, Carl D., Shimamura, Akiko, Ewart, Lorna, Ingber, Donald E.·2020·Nature Biomedical Engineering

Abstract

The inaccessibility of living bone marrow (BM) hampers the study of its pathophysiology under myelotoxic stress induced by drugs, radiation or genetic mutations. Here, we show that a vascularized human BM-on-a-chip (BM chip) supports the differentiation and maturation of multiple blood cell lineages over 4 weeks while improving CD34+ cell maintenance, and that it recapitulates aspects of BM injury, including myeloerythroid toxicity after clinically relevant exposures to chemotherapeutic drugs and ionizing radiation, as well as BM recovery after drug-induced myelosuppression. The chip comprises a fluidic channel filled with a fibrin gel in which CD34+ cells and BM-derived stromal cells are co-cultured, a parallel channel lined by human vascular endothelium and perfused with culture medium, and a porous membrane separating the two channels. We also show that BM chips containing cells from patients with the rare genetic disorder Shwachman–Diamond syndrome reproduced key haematopoietic defects and led to the discovery of a neutrophil maturation abnormality. As an in vitro model of haematopoietic dysfunction, the BM chip may serve as a human-specific alternative to animal testing for the study of BM pathophysiology. A vascularized human bone-marrow-on-a-chip improves the maintenance of patient-derived CD34+ cells, and recapitulates clinically relevant aspects of bone marrow injury as well as key haematopoietic defects of patients with a rare genetic disorder.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41551-019-0495-z

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 60 references

Cited by

See all 294

Metadata

Authors
Chou, D. B., Frismantas, V., Milton, Y., David, R., Pop-Damkov, P., Ferguson, D., MacDonald, A., Vargel Bölükbaşı, Ö., Joyce, C. E., Moreira Teixeira, L. S., Rech, A., Jiang, A., Calamari, E., Jalili-Firoozinezhad, S., Furlong, B. A., O’Sullivan, L. R., Ng, C. F., Choe, Y., Marquez, S., Myers, K. C., Weinberg, O. K., Hasserjian, R. P., Novak, R., Levy, O., Prantil-Baun, R., Novina, C. D., Shimamura, A., Ewart, L., & Ingber, D. E.
Venue
Nature Biomedical Engineering
Published
2020-01-27
Volume
4
Issue
4
Pages
394-406
ISSN
2157-846X (ISSN-L)
OpenAlex
W3002826985
Cited by
294
References
60
FWCI
12.75
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiology. https://app.cochat.ai/papers/10.1038/s41551-019-0495-z
The paper
Chou, D. B., Frismantas, V., Milton, Y., David, R., Pop-Damkov, P., Ferguson, D., MacDonald, A., Vargel Bölükbaşı, Ö., Joyce, C. E., Moreira Teixeira, L. S., Rech, A., Jiang, A., Calamari, E., Jalili-Firoozinezhad, S., Furlong, B. A., O’Sullivan, L. R., Ng, C. F., Choe, Y., Marquez, S., . . . Ingber, D. E. (2020). On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiology. Nature Biomedical Engineering. https://doi.org/10.1038/s41551-019-0495-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.